ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Development and temporal validation of AI‐enhanced HEp‐2 indirect immunofluorescence image analysis for specific autoantibody prediction in systemic autoimmune rheumatic diseases

Study limitation reported by the research below: “Sample size tag reflects the combined development and validation cohorts (47,890 + 21,427 = 69,317); the full screened population was 512,959 but only 47,890 met inclusion criteria for development. Clinicians should note these are distinct groups.”

Papers